CUI JINGRONG JEAN (Chief Scientific Officer) sold 7.1% of their position (55.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.49M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−1.10K
Price / share
$41.46
Trade value
$45.61K
% of position
Common Stock
Shares
−3K
Price / share
$42.61
Trade value
$127.74K
% of position
Common Stock
Shares
−11.21K
Price / share
$43.72
Trade value
$490.19K
% of position
Common Stock
Shares
−2.89K
Price / share
$44.22
Trade value
$127.80K
% of position
Common Stock
Shares
−300.00
Price / share
$45.13
Trade value
$13.54K
% of position
Common Stock
Shares
−4.50K
Price / share
$43.69
Trade value
$196.60K
% of position
Common Stock
Shares
−8.10K
Price / share
$44.96
Trade value
$364.18K
% of position
Common Stock
Shares
−5.90K
Price / share
$45.63
Trade value
$269.22K
% of position
Common Stock
Shares
−6.29K
Price / share
$45.88
Trade value
$288.80K
% of position
Common Stock
Shares
−12.11K
Price / share
$46.43
Trade value
$562.08K
% of position
Common Stock
Shares
−100.00
Price / share
$47.23
Trade value
$4.72K
% of position
Net shares
−55.50K
Net value
-$2.49M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/6/2020 | S · Sale | −1.10K | $41.46 | $45.61K | 0.1% | 782.09K | 780.99K |
| Common Stock Indirect | 4/6/2020 | S · Sale | −3K | $42.61 | $127.74K | 0.4% | 780.99K | 777.99K |
| Common Stock Indirect | 4/6/2020 | S · Sale | −11.21K | $43.72 | $490.19K | 1.4% | 777.99K | 766.78K |
| Common Stock Indirect | 4/6/2020 | S · Sale | −2.89K | $44.22 | $127.80K | 0.4% | 766.78K | 763.89K |
| Common Stock Indirect | 4/6/2020 | S · Sale | −300.00 | $45.13 | $13.54K | 0.0% | 763.89K | 763.59K |
| Common Stock Indirect | 4/7/2020 | S · Sale | −4.50K | $43.69 | $196.60K | 0.6% | 763.59K | 759.09K |
| Common Stock Indirect | 4/7/2020 | S · Sale | −8.10K | $44.96 | $364.18K | 1.1% | 759.09K | 750.99K |
| Common Stock Indirect | 4/7/2020 | S · Sale | −5.90K | $45.63 | $269.22K | 0.8% | 750.99K | 745.09K |
| Common Stock Indirect | 4/8/2020 | S · Sale | −6.29K | $45.88 | $288.80K | 0.8% | 745.09K | 738.80K |
| Common Stock Indirect | 4/8/2020 | S · Sale | −12.11K | $46.43 | $562.08K | 1.6% | 738.80K | 726.69K |
| Common Stock Indirect | 4/8/2020 | S · Sale | −100.00 | $47.23 | $4.72K | 0.0% | 726.69K | 726.59K |
| Total | −55.50K | -$2.49M | ||||||
Common Stock
DirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Direct |
| Common Stock | 300K | Indirect |
| Total | 1.30M | 1M direct·300K indirect |